Search
Now showing items 1-8 of 8
Effects of transdermal and oral hormone replacement therapies on monocytechemoattractant protein-1 (MCP-1) levels
(Elsevier Science Inc, 2013)
Estrogen priming GnRH antagonist regimen is an efficient protocol in poor responders
(Elsevier Science Inc, 2013)
The cycle outcomes of gnrh agonist triggering with different leuprolide acetate doses in high responder patients
(Elsevier Science Inc, 2014)
Serum and peritoneal fluid levels of ischemia modified albumin in endometriosis
(Elsevier Science Inc, 2014)
Ten years experience with poor responder patients fulfilling bologna criteria
(Elsevier Science Inc, 2014)
Follicular fluid total antioxidant capacity and ischemia modified albumin levels in polycystic ovary syndrome
(Elsevier Science Inc, 2014)
Testosterone and andropause: the effect of testosterone therapy
(Ortadogu Ad Pres & Publ Co, 2008)
There is a progressive reduction in male hypothalamic-pituitary-gonadal (HPG) axis function: testosterone levels decline through both central (pituitary) and peripheral (testicular) mechanisms, and there is a loss of the ...